Trial Profile
A Phase 2, Multicenter, Double-Blind, Placebo-Controlled Study of GBT009 for Treatment of Incisional Wounds Following Breast Reconstruction Surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 May 2014
Price :
$35
*
At a glance
- Drugs GBT 009 (Primary)
- Indications Scars
- Focus Therapeutic Use
- Sponsors Garnet BioTherapeutics
- 02 May 2014 New trial record